MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1016/j.jfma.2021.06.015

Медицинская библиотека · Journal of the Formosan Medical Association = Taiwan yi zhi · 2021

Bone marrow plasma level of decorin may be associated with improved treatment outcomes in a subset of multiple myeloma patients.

Huang Shang-Yi, Lin Hsiu-Hsia, Yao Ming, Tang Jih-Luh, Wu Shang-Ju, Chou Wen-Chien, Hsu Szu-Chun, Ko Bor-Sheng, Tien Hwei-Fang

СтатьяПеревод в очереди

Аннотация

BACKGROUND/PURPOSE: Decorin is a small leucine-rich proteoglycan rich in extracellular matrix with potential antitumor activity. However, the role of decorin in hematological malignancies remains unclear, especially in the case of multiple myeloma (MM), a bone marrow (BM) stroma-dependent plasma cell neoplasm.

METHODS

We measured decorin levels in BM plasma samples from 270 patients with newly diagnosed MM (NDMM) using enzyme-linked immunosorbent assays.

RESULTS

Patients were divided into high decorin (H-DCN, > 18.99 ng/mL) and low decorin (L-DCN <9.76 ng/mL) groups. Patients in the H-DCN group had more advanced-stage disease, including more osteolysis terms of higher levels of C-terminal telopeptides of type I collagen (0.69 ± 0.55 vs. 0.49 ± 0.36 ng/mL; P = 0.028), than those in the L-DCN group. Decorin levels correlated positively with hepatocyte growth factor (HGF) levels in BM plasma samples from NDMM patients (Pearson correlation coefficient, 0.226; P < 0.001). Patients with low HGF (<0.79 ng/mL) but high decorin levels (≥12.95 ng/mL) had a higher treatment response rate (90.5% vs. 54.5%, respectively; P = 0.015) and improved overall survival (not reached vs. 53 months; P = 0.0148) than those with lower decorin levels (<12.95 ng/mL). Multivariate analysis confirmed that a high decorin level was an independent predictive factor for treatment response and survival in patients with low HGF levels.

CONCLUSION

Our findings suggest that decorin may exert protective effects in this subset of MM patients.

Для цитирования: Huang Shang-Yi, Lin Hsiu-Hsia, Yao Ming, Tang Jih-Luh, Wu Shang-Ju, Chou Wen-Chien, Hsu Szu-Chun, Ko Bor-Sheng, Tien Hwei-Fang. Bone marrow plasma level of decorin may be associated with improved treatment outcomes in a subset of multiple myeloma patients.. Journal of the Formosan Medical Association = Taiwan yi zhi. 2021. DOI: 10.1016/j.jfma.2021.06.015.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.